EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Acute Intermittent Porphyria Triggered by COVID ‐19 Mimicking Guillain–Barré Syndrome: A Diagnostic Challenge

Payman Sadeghi iD, Masood Ghahvechi Akbari, Seyed Abbas Hassani, Hosein Alimadadi, Morteza Heidari, Vahid Ziaee iD

Clinical Case Reports · 2026-05 · 14 (5)

DOI: 10.1002/ccr3.72417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 04.05.2026. Verfasst von Payman Sadeghi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center Pediatrics Center of Excellence Tehran Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute intermittent porphyria (AIP) is a rare heme biosynthesis disorder in which the accumulation of neurotoxic porphyrin precursors precipitates neurovisceral attacks. Intercurrent infections, including coronavirus disease 2019 (COVID‐19), may trigger or exacerbate AIP and complicate diagnosis, as clinical manifestations can resemble those of other acute neuropathies. This report describes a 16‐year‐old girl who developed abdominal pain, seizures, and rapidly progressive acute motor neuropathy shortly after COVID‐19 and was initially misdiagnosed with Guillain–Barré syndrome (GBS). Diagnostic evaluation included electrophysiological studies, biochemical assays for porphyrin precursors, and genetic testing. AIP was suspected based on electrophysiological findings and elevated porphyrin precursors. The patient improved after initiation of a 10% dextrose infusion and a high‐carbohydrate diet, with normalization of laboratory abnormalities. Subsequent genetic testing identified a heterozygous pathogenic HMBS variant (c.580C> T), confirming AIP. COVID‐19 may unmask AIP and mimic a GBS‐like neuropathy, increasing the risk of delayed recognition and suboptimal management. In patients with COVID‐19‐associated acute neuropathy—particularly when accompanied by abdominal pain, seizures, or neuropsychiatric features—clinicians should include AIP in the differential diagnosis and pursue prompt biochemical evaluation (urine PBG and ALA) to facilitate early targeted therapy and prevent complications.

Schlagwörter

Stichwörter der Autor:innen

COVID‐19Guillain–Barré syndromeabdominal painacute intermittent porphyriaperipheral neuropathy

Autor:innen und Institutionen

  • Children's Medical Center Pediatrics Center of Excellence Tehran Iran.
  • Department of Pediatrics Tehran University of Medical Sciences Tehran Iran.
  • Pediatric Rheumatology Research Group, Rheumatology Research Center Tehran University of Medical Sciences Tehran Iran.
  • Pediatric Rheumatology Society of Iran Tehran Iran.
  • Department of Physical Medicine and Rehabilitation Tehran University of Medical Sciences Tehran Iran.
  • Division of Pediatric Intensive Care Tehran University of Medical Sciences Tehran Iran.

ORCID-Profile: Payman Sadeghi, Vahid Ziaee

Zitieren

APA

Sadeghi, P., Ghahvechi Akbari, M., Hassani, S. A., Alimadadi, H., Heidari, M., & Ziaee, V. (2026). Acute Intermittent Porphyria Triggered by COVID ‐19 Mimicking Guillain–Barré Syndrome: A Diagnostic Challenge. Clinical Case Reports, 14(5). https://doi.org/10.1002/ccr3.72417

Vancouver

Sadeghi P, Ghahvechi Akbari M, Hassani SA, Alimadadi H, Heidari M, Ziaee V. Acute Intermittent Porphyria Triggered by COVID ‐19 Mimicking Guillain–Barré Syndrome: A Diagnostic Challenge. Clinical Case Reports. 2026;14(5). doi:10.1002/ccr3.72417

BibTeX
@article{Sadeghi2026,
  author = {Sadeghi, Payman and Ghahvechi Akbari, Masood and Hassani, Seyed Abbas and Alimadadi, Hosein and Heidari, Morteza and Ziaee, Vahid},
  title = {Acute Intermittent Porphyria Triggered by COVID ‐19 Mimicking Guillain–Barré Syndrome: A Diagnostic Challenge},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {5},
  doi = {10.1002/ccr3.72417}
}
Kostenlos starten →